Sign in
Taking people in United StatesNo phase

TMS to Improve Recovery Outcomes Among Patients With Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD)

Key facts

Who runs it
Washington State University
Where
Portland, United StatesSee the site
Trial code
Status
Recruiting
People taking part
60 people, planned
Starts
1 Jun 2027
Expected to end
1 Oct 2027
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • TMS Low-Dose
  • TMS High-Dose
Record updated
29 May 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • 18+ years old
  • Enrolled in the Intensive Outpatient Program at Another Chance Drug \& Alcohol Rehab Center of Portland, Portland, OR
  • Diagnosed with Opioid Use Disorder
  • Diagnosed with Alcohol Use Disorder

Who cannot take part

  • Currently taking prescription benzodiazepines or anti-convulsive medications
  • History of seizure disorder diagnosis
  • History of Schizophrenia, Bipolar Disorder, Mania
  • Children <18 years old
  • Pregnant
  • Non-English speaking
  • In active alcohol or opioid withdrawal

Where in United States

  • Another Chance Drug & Alcohol Rehab Center of PortlandPortland, United StatesContact: John Morgan, CADC II, QMHATaking people

About the trial

What the trial wants to find out

The study aims to explore the potential of Transcranial Magnetic Stimulation (TMS), particularly Theta Burst Stimulation (TBS), as an adjunctive treatment to enhance recovery outcomes (consumption and craving; withdrawal symptoms; mental, physical, sleep, and cognitive health; engagement with therapy, etc.) in individuals with Opioid Use Disorder (OUD) and individuals with Alcohol Use Disorder (AUD). This project will be completed in partnership with Another Chance Rehab (Portland): Portland's top addiction treatment program offering evidence-based treatment programs for a range of substance use disorders. Another Chance Rehab will serve as the project site for this work.

The 3 groups in the trial

  • Treatment As UsualNo study treatment, for comparison

    Study participants in this arm will engage in intensive outpatient alcohol and addiction treatment provided as it usually is for all patients in this program.

  • 3-Minute TMSExisting treatment, for comparison

    TAU + 3-minute TMS: Participants complete TAU as described above, with one 3-minute session of TMS TBS delivered each morning, prior to commencement of their regularly scheduled daily therapy activities, for 5 days/week, for a total of four-weeks (20 sessions total).

    Treatment: TMS Low-Dose

  • 9-Minute TMSExisting treatment, for comparison

    TAU + 9-minute TMS: Participants complete TAU as described above, with one 9-minute session of TMS TBS delivered each morning, prior to commencement of their regularly scheduled daily therapy activities, for 5 days/week, for a total of four-weeks (20 sessions total).

    Treatment: TMS High-Dose

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Transcranial Magnetic Stimulation (TMS) to Improve Recovery Outcomes Among Patients With Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD)
Record updated
29 May 2026